Advanced Search
Contact | Corporate | Help

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM

Sponsors:
  • H. Lee Moffitt Cancer Center and Research Institute
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Mesothelioma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Carboplatin, Bevacizumab and Pemetrexed
Enrollment:
48

Additional information about NCT00604461.


SourceSolution © 2008-2012